Dipharma SA is a Swiss pharmaceutical company specialized in developing generic high quality medicines for rare metabolic diseases.
The company is part of the Dipharma Group, a third generation family company founded in 1949 and grown to a global presence.
Our mission is to improve the quality of life of patients affected by rare metabolic diseases, providing them with high quality, improved medicines at an affordable cost.
Become the reference company for doctors, patients and patients families in treating rare metabolic diseases.
We are working on our new websites, sorry for the inconvenience.
For pharmacovigilance enquiries please click here